In a new statement published on 3 September, the BioMed Alliance calls on the German Council Presidency to guide Member States into adopting a position on the Regulation for Cooperation on Health Technology Assessment as soon as possible. The statement also recalls a previous BioMed Alliance statement from 2019 calling for the proposal to swiftly be adopted. Since then, limited progress has been made.

Cooperation on HTA has numerous benefits for the European health system and could enhance coordination, reduce duplication, improve efficiency, reduce costs and lead to better treatments for patients. The coronavirus crisis has illustrated the importance of having a legally sound and functioning HTA system in place that could help the EU to prepare for future health crises.

Read the statement here, and our previous statement from 2019 here.

HTA

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.